Lung Cance
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) . (NCT04234620) | Shanghai Junshi Bioscience Co., Ltd. | 2020-02-15 |
Track Lung Cance automatically
Every clearance here is in the API, with alerts when new ones post.